A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer

Randolph S. Marks, David L. Graham, Jeff A. Sloan, Shauna Hillman, Steven Fishkoff, James E. Krook, Scott H. Okuno, James A. Mailliard, Tom R. Fitch, Ferdinand Addo

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences